immunotherapy for autoimmune diseases, such as uveitis, has been aimed at controlling CD4 autoreactive T cells. In this application, we propose to test a new approach, namely whether impeding the interaction between CD4 and CDS autoreactive T cells halts the progression of autoimmune uveitis. This hypothesis is supported by our findings that the adoptive transfer of in vitro activated interphotoreceptor retinoid-binding protein (IRBP)-specific T cells reproducibly induces chronic and/or recurrent uveitis in both rats and mice and that the pathogenic T cells that induce the disease contain a significant proportion of vigorously proliferating cells expressing CD8. We hypothesize that the progression of autoimmune uveitis is a consequence of the activation of increasing numbers of CDS autoreactive T cells which have a stronger tissue-damaging capability when they become highly activated, due to their greater cytotoxic activity and also because of the expression of MHC I molecules, required for T cell action, in the autoimmune organ. In this hypothesis, in the absence of CDS T cell activation, CD4 IRBP-specific T cells would induce only mild or monophasic uveitis, whereas, when CDS T cells are activated, severe recurrent uveitis would result. We will determine whether the reciprocal interaction between CD4 and CDS autoreactive T cells leads to severe tissue damage and disease progression and whether impeding this interaction blocks disease progression (Aim 1). We will also determine the factors that cause increased activation of CDS autoreactive T cells (Aim 2). Based on our preliminary results that T cells regulating autoimmune disease express high amounts of Foxp3 and that a subset of CDS IRBP-specific T cells expresses higher levels of FoxpS, we will also determine whether pathogenic CDS autoreactive T cells can be distinguished from suppressive CDS T cells by the levels of FoxpS expressed (Aim 3). Chronic and recurrent uveitis pose the highest risk for ocular complications leading to blindness in humans. To provide a working model allowing the dissection of the pathogenesis of recurrent uveitis, we have established a chronic, non-recurrent model of uveitis in the mouse and a chronic, recurrent model in the rat. Studies on the interrelationship between CD4 and CDS autoreactive T cells should provide much-needed insights into the pathogenic mechanism leading to disease progression and help in the development of supplemental therapies for this devastating disease.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY017373-05
Application #
8024494
Study Section
Anterior Eye Disease Study Section (AED)
Program Officer
Mckie, George Ann
Project Start
2008-03-01
Project End
2013-02-28
Budget Start
2011-03-01
Budget End
2013-02-28
Support Year
5
Fiscal Year
2011
Total Cost
$296,335
Indirect Cost
Name
Doheny Eye Institute
Department
Type
DUNS #
020738787
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Sun, Deming; Liang, Dongchun; Kaplan, Henry J et al. (2015) The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine 74:76-80
Liang, Dongchun; Zuo, Aijun; Shao, Hui et al. (2013) Retinoic acid inhibits CD25+ dendritic cell expansion and ?? T-cell activation in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 54:3493-503
Nian, Hong; Liang, Dongchun; Zuo, Aijun et al. (2012) Characterization of autoreactive and bystander IL-17+ T cells induced in immunized C57BL/6 mice. Invest Ophthalmol Vis Sci 53:897-905
Liang, Dongchun; Zuo, Aijun; Shao, Hui et al. (2012) Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis. J Immunol 188:5785-91
Zuo, Aijun; Liang, Dongchun; Shao, Hui et al. (2012) In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via ýýýý T cell activation. Mol Immunol 50:125-33
Ankathatti Munegowda, Manjunatha; Deng, Yulin; Chibbar, Rajni et al. (2011) A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. J Clin Immunol 31:811-26
Ke, Yan; Sun, Deming; Jiang, Guomin et al. (2011) IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol 187:2130-9
Ke, Yan; Jiang, Guomin; Sun, Deming et al. (2011) Anti-CD3 antibody ameliorates experimental autoimmune uveitis by inducing both IL-10 and TGF-? dependent regulatory T cells. Clin Immunol 138:311-20
Nian, Hong; Shao, Hui; O'Brien, Rebecca L et al. (2011) Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest Ophthalmol Vis Sci 52:5920-7
Ke, Yan; Sun, Deming; Jiang, Guomin et al. (2010) PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells. J Leukoc Biol 88:1241-9

Showing the most recent 10 out of 29 publications